Updates on Abstract 397600: ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab +- etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC)
Domvanalimab;Zimberelimab;Etrumadenant;Zimberelimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updates on Abstract 397600: ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab +- etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC) ### Output: Domvanalimab;Zimberelimab;Etrumadenant;Zimberelimab